JPSIM is supported by PSIM, nominal submission and processing fees, and a limited number of advertisements from pharmaceutical companies in its print edition. Advertising income is used to help meet the journal’s printing costs. The journal may also receive legitimate institutional support, grants or sponsorship. All financial arrangements are administered so that funders and advertisers have no role in manuscript selection, peer review or editorial decisions.
The Editor-in-Chief, Editor, Associate Editors, Assistant Editors, Editorial Board members, and members and Chairmen of the National and International Advisory Boards serve in an honorary capacity and receive no payment for their positions. The Managing Editor and journal-office staff receive monthly salaries determined by the President of PSIM and revised from time to time as necessary. Remuneration for operational work does not confer authority over scientific decisions.
Relevant financial relationships must be disclosed by authors, reviewers and editors. Any individual whose financial interest could reasonably affect judgment shall not participate in handling the relevant manuscript. Sources of material support for a study and the sponsor’s role shall be disclosed in the published article.